ATE177113T1 - Neue verbindungen und konjugate - Google Patents

Neue verbindungen und konjugate

Info

Publication number
ATE177113T1
ATE177113T1 AT93909297T AT93909297T ATE177113T1 AT E177113 T1 ATE177113 T1 AT E177113T1 AT 93909297 T AT93909297 T AT 93909297T AT 93909297 T AT93909297 T AT 93909297T AT E177113 T1 ATE177113 T1 AT E177113T1
Authority
AT
Austria
Prior art keywords
compound
group
enzyme
conjugates
protein
Prior art date
Application number
AT93909297T
Other languages
English (en)
Inventor
Paul S Palumbo
Original Assignee
Behring Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behring Diagnostics Inc filed Critical Behring Diagnostics Inc
Application granted granted Critical
Publication of ATE177113T1 publication Critical patent/ATE177113T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT93909297T 1992-04-23 1993-04-08 Neue verbindungen und konjugate ATE177113T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/872,539 US5294536A (en) 1992-04-23 1992-04-23 Conjugates

Publications (1)

Publication Number Publication Date
ATE177113T1 true ATE177113T1 (de) 1999-03-15

Family

ID=25359788

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93909297T ATE177113T1 (de) 1992-04-23 1993-04-08 Neue verbindungen und konjugate

Country Status (9)

Country Link
US (1) US5294536A (de)
EP (1) EP0606411B1 (de)
JP (1) JPH06508639A (de)
AT (1) ATE177113T1 (de)
AU (1) AU662627B2 (de)
CA (1) CA2101734A1 (de)
DE (1) DE69323713T2 (de)
ES (1) ES2130257T3 (de)
WO (1) WO1993022677A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU670674B2 (en) * 1993-01-06 1996-07-25 Beckman Instruments, Inc. Method for making a preconjugate
US5548064A (en) * 1993-05-24 1996-08-20 Biotech Australia Pty Limited Vitamin B12 conjugates with EPO, analogues thereof and pharmaceutical compositions
US5869465A (en) * 1994-04-08 1999-02-09 Receptagen Corporation Methods of receptor modulation and uses therefor
US5739287A (en) * 1994-04-08 1998-04-14 University Of Washington Biotinylated cobalamins
DE69528523T2 (de) * 1994-04-08 2003-06-12 Receptagen Corp Rezeptor modulierendes mitteln und entsprechendes verfahren
SE9600229D0 (sv) * 1996-01-23 1996-01-23 Pharmacia Ab Novel potentiating agents
AU737926B2 (en) * 1996-05-20 2001-09-06 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Oligonucleotides which specifically bind retroviral nucleocapsid proteins
DE19636889A1 (de) * 1996-09-11 1998-03-12 Felix Dr Kratz Antineoplastisch wirkende Transferrin- und Albuminkonjugate zytostatischer Verbindungen aus der Gruppe der Anthrazykline, Alkylantien, Antimetabolite und Cisplatin-Analoga und diese enthaltende Arzneimittel
US5977299A (en) * 1997-04-07 1999-11-02 Dade Behring Marburg Gmbh Activated peptides and conjugates
AUPP405098A0 (en) * 1998-06-12 1998-07-02 Access Pharmaceuticals Australia Pty Limited Novel methods of preparation of vitamin b12 derivatives suitable for conjugation to pharmaceuticals
US6210908B1 (en) 1998-11-11 2001-04-03 Dade Behring Marburg Gmbh Activated peptides and conjugates
US6743585B2 (en) 1999-09-16 2004-06-01 Agilent Technologies, Inc. Methods for preparing conjugates
US6797521B2 (en) * 1999-10-26 2004-09-28 University Of Utah Research Foundation Fluorescent cobalamins and uses thereof
WO2012142659A1 (en) * 2011-04-19 2012-10-26 Baker Idi Heart And Diabetes Institute Holdings Limited Site-selective modification of proteins
US9120858B2 (en) 2011-07-22 2015-09-01 The Research Foundation Of State University Of New York Antibodies to the B12-transcobalamin receptor
CN107973836B (zh) * 2017-10-19 2020-05-12 苏州博源医疗科技有限公司 醛固酮衍生物及其制备方法、醛固酮均相酶免疫检测试剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5272284A (en) * 1975-12-12 1977-06-16 Dainippon Pharmaceutical Co Enzymeeimmunoassay reagent
US4760142A (en) * 1984-11-27 1988-07-26 Hoechst Celanese Corporation Divalent hapten derivatives
JPH01199573A (ja) * 1987-10-25 1989-08-10 Kuraray Co Ltd スーパーオキシドジスムターゼ誘導体およびその製造法
CA1340387C (en) * 1987-10-30 1999-02-09 Carol A. Schlesinger Heterobifunctional coupling agents
US4994385A (en) * 1987-10-30 1991-02-19 Abbott Laboratories Heterobifunctional coupling agents
US5002883A (en) * 1987-10-30 1991-03-26 Abbott Laboratories Covalent attachment of antibodies and antigens to solid phases using extended length heterobifunctional coupling agents
CA2015938C (en) * 1989-05-02 1999-09-07 Kevin M. Knigge Covalent attachment of specific binding members to a solid phase

Also Published As

Publication number Publication date
AU3976393A (en) 1993-11-29
CA2101734A1 (en) 1993-10-24
EP0606411A1 (de) 1994-07-20
ES2130257T3 (es) 1999-07-01
DE69323713D1 (de) 1999-04-08
US5294536A (en) 1994-03-15
AU662627B2 (en) 1995-09-07
WO1993022677A1 (en) 1993-11-11
JPH06508639A (ja) 1994-09-29
EP0606411B1 (de) 1999-03-03
DE69323713T2 (de) 1999-07-01

Similar Documents

Publication Publication Date Title
DE69323713D1 (de) Neue verbindungen und konjugate
ATE130197T1 (de) Heterofunktionelle zellular immunologische reagenzien, impfstoffe daraus und verwendungsverfahren.
DK0693132T3 (da) Rapamycinassay
KR870003195A (ko) 단일클론 항체를 이용한 그램 네가티브 박테리아 감염증의 검진 방법
DE68922385T2 (de) Neuer monoklonaler Antikörper gegen menschliches Karzinom.
MY104946A (en) Antigen antibody conjugate.
CA2150925A1 (en) Improved synthesis of polymer bio-active conjugates
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
ES2123677T3 (es) Ligadores de maleinimida trifuncionales homobidentados y su uso en conjugados inmunologicamente activos.
ATE71411T1 (de) Monoklonale antikoerper mit spezifitaet fuer membran-assoziierte antigene.
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ATE74662T1 (de) Immunoanalysetestverfahren fuer cholesterolepoxide.
ATE468533T1 (de) Enzym-protein-komplex
EP0028132A3 (de) Verfahren zur passiven Adsorption immunoreaktiver Haptene auf festen Phasen
DE69231495D1 (de) Neue cocain-derivate und protein- und polypeptid-cocain-derivate, konjugate und markierte verbindungen
NO168746C (no) Antistoff som er istand til aa binde histamin
FR2422699A1 (fr) Procede de preparation d'un materiau solide poreux revetu de cellulose ou de cellulose modifiee
DE69025023T2 (de) Peptide und deren Benutzung
ATE80467T1 (de) Immuntestverfahren.
EA200100287A1 (ru) Высокоаффинные антитела
DK0994121T3 (da) Forgrenede peptider i analyser for antistoffer
FI861715A0 (fi) Monoklonal antiurokinase-antikropp, den innehaollande matris och biokemiska testpackningar, i vilka den anvaendes.
ATE81909T1 (de) Hybridomen-tumor-zellinien und deren monoklonale antikoerper gegen thaumatin.
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties